https://www.marketscreener.com/quote/stock/SUMITOMO-PHARMA-CO-LTD-6492512/news/Sumitomo-Pharma-Announces-Positive-Topline-Results-from-Phase-3-Clinical-Studies-Evaluating-Vibegron-44814663/?utm_source=telegram&utm_medium=social&utm_campaign=share